Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2005
Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumoursP Schöffski, I Breidenbach, J Krauter, et al.
Arzneimittel-Forschung|June 25, 1998
Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungsK Weber, U Mengs, T Schwarz, et al.
Natural Immunity|October 28, 1998
Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivoT Hajto, K Hostanska, K Weber, et al.
Anticancer Research|March 26, 2002
Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent miceB Schaffrath, U Mengs, T Schwarz, et al.
Arzneimittel-Forschung|June 1, 1996
Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassayP W Joller, J M Menrad, T Schwarz, et al.
British Journal of Cancer|December 1, 1996
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activityC Bokemeyer, L M Fels, T Dunn, et al.
FEBS Letters|August 26, 1998
Mistletoe lectin I forms a double trefoil structureE C Sweeney, A G Tonevitsky, R A Palmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development GroupP Schöffski, S Riggert, P Fumoleau, et al.
Pageof 4